Holen Sie sich die Stockscreener-App
0.9487
5.13%
-0.0513
Handel nachbörslich:
.94
-0.0087
-0.92%
Schlusskurs vom Vortag:
$1.00
Offen:
$1
24-Stunden-Volumen:
447.05K
Relative Volume:
14.29
Marktkapitalisierung:
$19.45M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-4.18%
1M Leistung:
+0.00%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$0.9301
$1.05
1-Wochen-Bereich:
$0.903
$1.09
52-Wochen-Spanne:
$0.903
$1.09
Ping An Biomedical Co Ltd Stock (PASW) Company Profile
Firmenname
Ping An Biomedical Co Ltd
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie PASW mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PASW
Ping An Biomedical Co Ltd
|
0.9487 | 20.50M | 0 | 0 | 0 | 0.00 |
|
AIN
Albany International Corp
|
53.69 | 1.62B | 1.27B | 100.39M | 116.84M | 3.20 |
|
UFI
Unifi Inc
|
4.58 | 85.19M | 583.56M | -53.59M | -18.48M | -2.97 |
|
CULP
Culp Inc
|
4.21 | 54.08M | 237.23M | -13.64M | -6.50M | -1.10 |
Ping An Biomedical Co Ltd Aktie (PASW) Neueste Nachrichten
Majestic Ideal Holdings to become Ping An Biomedical with new Nasdaq ticker - Investing.com
Majestic Ideal Holdings to rebrand as Ping An Biomedical - Investing.com
Majestic Ideal Holdings Ltd Proposes Name Change to Ping An Biomedical Co., Ltd. - TipRanks
Why Celcuity Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket - Benzinga
Majestic Ideal Holdings Limited Announced Closing of Initial Public Offering - 富途牛牛
Why Block Shares Are Trading Higher By 10%; Here Are 20 Stocks Moving Premarket - Benzinga
MJIDMajestic Ideal Latest Stock News & Market Updates - Stock Titan
Mulberry Leaf Extract and Deoxynojirimycin Modulates Glucose and Lipid Levels via the IRS1/PI3K/AKT Signaling Pathway in Cells - Wiley Online Library
Six NUS researchers honoured with prestigious SNAS FellowshipsNUS - NUS - National University of Singapore
RSPSSL: A novel high-fidelity Raman spectral preprocessing scheme to enhance biomedical applications and chemical resolution visualization - Nature
Enhanced tumor control activities of anti-mPD-L1 antibody and antigen-presenting cell-like natural killer cell in an allograft model - BMC Cancer
Development and quantitative assessment of deep learning-based image enhancement for optical coherence tomography - BMC Ophthalmology
NCKU Celebrates Anniversary with Three Award Ceremonies - mail.ncku.edu.tw
Ping An Research on AI Applications for retinal imaging selected at medical imaging conference - Healthcare Radius
Identification and characterization of related substances in pomalidomide by hyphenated LC–MS techniques - ScienceDirect.com
Finanzdaten der Ping An Biomedical Co Ltd-Aktie (PASW)
Es liegen keine Finanzdaten für Ping An Biomedical Co Ltd (PASW) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
1.86%
Kapitalisierung:
|
Volumen (24h):